.svg){kind=small}
Nov-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
The Tablet has demonstrated consistent performance in the Capsules category within California. Over the months from August to November 2025, the brand maintained a steady rank at number 7, indicating a strong foothold in the market. This stability suggests a loyal customer base and effective market strategies. Notably, there was a significant increase in sales from October to November, with sales rising from $171,455 to $190,994, reflecting a positive trend that could be attributed to seasonal demand or successful promotional activities.
Despite the consistent ranking in California, it's important to highlight that The Tablet did not appear in the top 30 brands for any other state or category during this period. This absence could be viewed as a potential area for growth and expansion, as the brand might be missing out on opportunities in other markets. The focus on California could mean that the brand is concentrating its efforts and resources in a single market, which might pay off in terms of deep market penetration but also poses a risk if market conditions change. Exploring strategies to break into other states could help diversify their market presence and reduce dependency on a single region.
Competitive Landscape
In the competitive landscape of the California capsules category, The Tablet consistently held the 7th rank from August to November 2025, indicating a stable position amidst fluctuating market dynamics. Despite its steady rank, The Tablet's sales showed a positive upward trend, particularly in November 2025, where it saw a significant increase compared to previous months. This growth trajectory is noteworthy, especially when juxtaposed with competitors such as Papa & Barkley, which experienced a drop in rank from 9th to 10th place, and Emerald Bay Extracts, which maintained a consistent 6th rank but saw a decline in sales. Meanwhile, Buddies held a strong 5th position throughout, with sales figures significantly higher than The Tablet. The rise of Dr. Norm's from not being in the top 20 in August to reaching the 9th position by November highlights the dynamic nature of this market. These insights suggest that while The Tablet maintains a stable rank, its increasing sales could potentially position it for upward mobility in the competitive rankings.
Notable Products
In November 2025, the top-performing product for The Tablet was the Indica High Dose Tablets 50-Pack (1000mg) in the Capsules category, maintaining its first-place rank consistently from August through November, with notable sales of 1479 units. The Sativa Tablets 20-Pack (1000mg) secured the second position, showing a significant increase in sales to 1234 units, up from third place in September. The Sativa High Dose Tablets 50-Pack (1000mg) followed closely in third place, a position it has consistently held except for September. Indica Tablets 20-Pack (1000mg) remained steady at fourth place throughout these months. Overall, the rankings for these products have shown remarkable stability, with the primary changes being between the second and third positions.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
